Prognostic Impact of Residual T and N Status After Neoadjuvant Therapy in Breast Cancer
{{output}}
Background/aim: Residual disease after neoadjuvant systemic therapy (NST) is strongly associated with prognosis in breast cancer. However, currently available indices such as the Residual Cancer Burden (RCB) and Neo-Bioscore are ... ...
